Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
09.02.26
/
50%
€164.40
Target price
09.02.27
-
Performance (%)
14.29%
Price
12:50
€187.90
Summary
This prediction is currently active. The prediction currently has a performance of 14.29%. This prediction currently runs until 09.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 4.714% | 4.714% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat